FCL Launches Face Lift Matrix and Neck Firming Complex

Gurugram, July 30: FCL, the premium dermatologist-approved cosmeceutical brand from Fixderma, has expanded its advanced anti-ageing portfolio with the launch of Face Lift Matrix and Neck Firming Complex. Developed using clinically backed ingredients and dermatological expertise, the two formulations are designed to address visible signs of ageing, including loss of firmness, reduced elasticity and fine lines, while delivering specialised care for the face, jawline and neck.

As consumers become increasingly informed about skincare ingredients and preventive skin health, the conversation around ageing is evolving from correcting wrinkles to preserving skin quality, collagen health and elasticity. While facial skincare has advanced significantly, the neck and jawline remain among the most neglected areas despite being the first to show visible signs of ageing. Responding to this growing need, FCL’s latest innovations deliver targeted, science-backed solutions that support healthier, firmer and more resilient skin.

“The conversation around ageing is evolving. Today’s consumers are no longer chasing products that simply promise younger-looking skin, they want formulations that preserve skin quality, build resilience and deliver measurable results. At FCL, every innovation begins with understanding how the skin functions and what it truly needs at different stages of life. Face Lift Matrix and Neck Firming Complex address one of the most overlooked concerns in skincare, the gradual loss of firmness across the face, jawline and neck. By combining clinically proven actives with targeted delivery systems, we support collagen, strengthen the skin barrier and deliver healthier, firmer, more resilient skin.” – Shaily Mehrotra, CEO & Co-Founder, Fixderma & FCL

Face Lift Matrix

A high-performance anti-ageing cream developed to visibly improve skin firmness, elasticity and facial contours. Powered by advanced active ingredients, the formulation helps support collagen production, reduce the appearance of fine lines and wrinkles and improve overall skin texture while providing long-lasting hydration. Lightweight yet nourishing, it strengthens the skin barrier and leaves the skin looking smoother, firmer and revitalised.

Key Benefits

• Accelerates skin rejuvenation

• Enhances skin radiance

• Improves skin firmness & elasticity

• Reduces the appearance of fine lines & wrinkles

• Provides deep hydration

• Promotes overall skin remodelling

Experience the Legacy of Max Verstappen and Daniel Ricciardo at The Bay, Ecoworld with Oracle Red Bull Racing RB14 Display and Immersive Gaming Activations

Bengaluru, July 30: The Bay, Ecoworld brought the thrill of Formula 1 and motorsport-inspired gaming to Bengaluru through a series of immersive Red Bull experiences, giving employees a unique opportunity to witness an iconic Formula 1 car up close and test their racing skills in a state-of-the-art gaming environment.

The celebrations were headlined by the Oracle Red Bull Racing RB14 Formula 1 Static Car Display, which brought a replica of the iconic Oracle Red Bull Racing RB14 Formula 1 car to Bengaluru for the first time. Employees and visitors had a rare opportunity to experience the excitement of Formula 1 up close while learning about the RB14, the car raced by Formula 1 stars Max Verstappen and Daniel Ricciardo during the 2018 Formula One season.

The Bay, Ecoworld also hosted the Red Bull Gaming Ground, a two-day activation featuring a first-of-its-kind large-scale portable gaming lounge equipped with state-of-the-art racing simulators and PlayStation 5 gaming stations. Visitors participated in thrilling racing challenges, competed with colleagues for the fastest lap times and enjoyed an interactive gaming experience designed to recreate the intensity and adrenaline of motorsport.

Together, the two experiences reflected The Bay, Ecoworld‘s commitment to curating engaging lifestyle experiences that go beyond the workplace. By bringing together an iconic Formula 1 showcase, interactive gaming and cutting-edge racing simulators, the destination created memorable moments while reinforcing its position as a vibrant hub for community engagement, entertainment and experiential activations.

The Bay is an experiential F&B district located at Ecoworld, a marquee mixed-use development in Bengaluru managed by BGRE, a leading global developer and operator of high-quality real estate assets.

India Maintains Strong Economic Momentum as Global Uncertainties Persist

New Delhi, July 30: India’s economy continues to show resilience despite challenges in the global environment, according to the latest Finance Ministry report. The assessment highlights that strong domestic demand, steady investment, and ongoing policy support are helping the country maintain its growth momentum.

The report noted that while factors such as geopolitical tensions, global market fluctuations, and economic uncertainties remain areas of concern, India’s underlying economic fundamentals continue to provide stability. Key sectors, including manufacturing, services, infrastructure, and digital growth, are contributing to overall economic expansion.

The government has emphasized that continued reforms, improved business conditions, and investments in infrastructure will play an important role in sustaining long-term growth. Strong consumer activity and increasing private sector participation are also supporting the economy’s recovery and expansion.

The Finance Ministry said India remains focused on strengthening economic stability, encouraging innovation, and creating opportunities for inclusive growth. Despite external challenges, the country’s growth outlook remains positive, supported by its strong domestic foundation and reform-driven approach.

As global conditions continue to evolve, India is expected to maintain its focus on sustainable development and building a stronger, more resilient economy.

Flat June PCE forecast masks persistent U.S. services inflation, Truflation finds

Core PCE is forecast at 3.3% year-on-year, supporting a cautious, higher-for-longer Federal Reserve outlook

ZURICH, July 30 – Truflation, the independent, real-time economic data provider,  released its June U.S. Personal Consumption Expenditures Price Index (PCE) forecast, projecting flat headline inflation of 0.0% month-on-month and 3.7% year-on-year.

Key findings from Truflation’s June forecast include:

• Core inflation remained elevated: Core PCE, which excludes food and energy, is forecast to rise 0.2% month-on-month and 3.3% year-on-year, indicating that underlying inflationary pressures remain persistent.

• Services continued to drive underlying pressure: Healthcare and transportation costs rose during June, with transportation services recording the strongest monthly increase among the major categories tracked.

• Energy relief may prove temporary: Gasoline and energy goods prices fell 7.3% month-on-month, but renewed geopolitical tensions continue to pose upside risks to oil and gas prices.

Lower gasoline prices helped contain headline inflation during June as crude prices retreated and pump prices declined for five consecutive weeks following May’s increase.

Services inflation, however, remained resilient. Healthcare prices rose 0.26% month-on-month and 4.16% year-on-year, reflecting continued pressure from insurance, labor, and prescription drug costs. Transportation services increased 0.84% month-on-month and 11.0% year-on-year as airlines, transit systems, and ride-hailing platforms continued to pass through higher operating costs.

Softer prices in food services and accommodation, as well as furnishings and durable goods, provided some offset. Clothing and footwear prices were broadly unchanged on the month but remained 4.97% higher year-on-year as earlier tariff increases and higher import costs continued to feed through into retail pricing.

“The flat headline should not distract from the persistence of underlying inflation,” said Oliver Rust, Head of Data at Truflation. “Core inflation remains well above target, while healthcare and transportation services continue to place pressure on household costs. While this supports the case for the Federal Reserve to keep rates unchanged for now and maintain a higher-for-longer approach, any renewed energy pressures or a material upside inflation surprise could still bring further tightening back into consideration.”

Truflation’s PCE forecast draws on more than 15 million live price points that are updated daily from over 30 commercial and public data sources, using daily market-price data to provide an up-to-date view of inflation trends ahead of the official monthly release.

Employee Reserved Portion Sees Strong Response, subscribed 89 percent on Day 1; Manipal Health Enterprises IPO Subscribed 15 percent

Mumbai, July 30: The Initial Public Offering (IPO) of Manipal Health Enterprises Limited was subscribed 0.15 times on the first day of bidding, with participation from retail, qualified institutional buyers (QIBs), non-institutional investors and employees.

The issue received bids for 1,30,96,350 equity shares against 9,00,88,286 equity shares on offer, according to data available on the stock exchanges.

The Retail Individual Investors (RII) portion was subscribed 0.25 times, the Non-Institutional Investors (NII) portion 0.07 times, the Qualified Institutional Buyers (QIBs) portion 0.14 times, and the Employee Reserved portion 0.89 times.

The issue kicked off for subscription on Wednesday, July 29, 2026, and will close for subscription on Friday, July 31, 2026.

A day before the opening of the issue, Manipal Health Enterprises Limited had raised Rs 4,167 crore from anchor investors. The anchor book witnessed participation from several marquee global institutional investors, including Abu Dhabi Investment Authority – Stable, Templeton Emerging Markets Fund and Allianz Global Investors Fund – Allianz India Equity, amongst others.

Brokerage houses recommend Manipal Health Enterprises

Leading brokerage firms like Anand Rathi, BP Wealth, Canara Bank Securities, ICICI Securities and SBI Securities have given their “Subscribe” recommendation to Manipal Health Enterprises Limited 

Anand Rathi highlights the company is the largest pan-India multispecialty hospital network by bed capacity and the second-largest hospital chain by number of hospitals as of March 31, 2026.

On the valuation front, at the upper price band, company is valued at a PE of 85.4 to its FY26 earnings with market cap of Rs 7,76,056 million post issue of equity shares. Recommend a “SUBSCRIBE” rating for the long-term. 

SBI Securities highlights the company delivers a comprehensive range of healthcare services which includes outpatient services to complex tertiary and quaternary interventions.

On the valuation front, at the upper price band of Rs 590, the issue is valued at an EV/EBITDA of 29.4 times based on FY26 Proforma earnings on a post-issue basis, which is fairly valued against industry peers. Recommend a “SUBSCRIBE” rating for the long-term.

IPO Details:

The IPO is a fresh issue of up to Rs 8,000 crore, and an offer-for-sale of up to 21,613,834 equity shares by promoters – Imperius Healthcare Investments Pte. Ltd, and Manipal Education and Medical Group India Private Limited.

Investors selling shares include TPG SG Magazine Pte. Ltd, Seventy Second Investment Company LLC, Ammar Sdn Bhd, Novo Holdings Invest Asia A/S and Phoenix Bear Investments, LLC.

The proceeds from its fresh issuance worth Rs 5,552.7 crore will be utilised for repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of the company’s material subsidiaries, Manipal Hospitals Private Limited, Rs 574 crore for acquisition of minority stake in the company’s step-down subsidiary, Sahyadri Hospitals Private Limited, and general corporate purposes.

Investors can bid for a minimum of 25 Equity Shares and in multiples of 25 Equity Shares thereafter. 

Company Information

The company operates a pan-India network of multispecialty hospitals delivering a comprehensive range of care services—from outpatient services to complex tertiary and quaternary interventions. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories.

The company has the widest footprint in terms of presence of hospitals among private hospital chains in India as of March 31, 2026 (Source: CRISIL Report). It is the largest pan-India multispecialty hospital network by bed capacity and the second-largest hospital chain by number of hospitals as of March 31, 2026 (Source: CRISIL Report).

For Fiscal 2026, the company reported the second-highest revenue from operations of ₹103,297.51 million (₹109,336.34 million on a pro forma basis) among private hospital chains in India (Source: CRISIL Report).

In its three key regions of Karnataka, Maharashtra and Goa and West Bengal, Odisha, Jharkhand, and Sikkim, the company had 6,404, 2,188 and 2,887 licensed beds, respectively, as of March 31, 2026.